Secondary analysis of a Nepal typhoid conjugate vaccine (Vi-TT) trial in children aged 9 months to 16 years: anti-Vi IgG GMC fell from 2037.90 at Day 28 to 109.3 at Year 5, with 88% keeping a ≥4-fold rise from baseline; decline was faster in younger children.
Secondary analysisn = 1,500
Pant et al. Persistence of immune responses 5 years after vaccination with a single dose of typhoid conjugate vaccine (TCV) in Nepalese children